Nuwellis, Inc. (NUWE)
| Market Cap | 2.83M |
| Revenue (ttm) | 8.17M |
| Net Income (ttm) | -16.56M |
| Shares Out | 1.87M |
| EPS (ttm) | -56.33 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,137 |
| Open | 1.600 |
| Previous Close | 1.600 |
| Day's Range | 1.500 - 1.650 |
| 52-Week Range | 1.500 - 56.280 |
| Beta | -0.11 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 10, 2026 |
About NUWE
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus... [Read more]
Financial Performance
In 2024, Nuwellis's revenue was $8.74 million, a decrease of -1.40% compared to the previous year's $8.86 million. Losses were -$10.62 million, -53.05% less than in 2023.
Financial StatementsNews
Nuwellis Appoints David A. McDonald and Martin J.
MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced t...
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced t...
Nuwellis Appoints Carisa Schultz as Chief Financial Officer
Schultz brings public company healthcare finance and medical technology experience to support Nuwellis' next phase of growth Schultz brings public company healthcare finance and medical technology exp...
Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on advancing precision cardiorenal care in critical car...
Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy
MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced th...
Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare
Nuwellis Inc (NASDAQ: NUWE) stock is on fire. Shares of the tiny medical device maker surged more than 100% in pre-market trading Tuesday and were still up around 85% by 10 AM ET in early trading, as ...
Nuwellis Announces Changes to Board of Directors
MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced th...
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy
Patent issuance strengthens pediatric intellectual property portfolio and advances system-level safety design Patent issuance strengthens pediatric intellectual property portfolio and advances system-...
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
Findings reinforce Nuwellis' leadership in precision ultrafiltration for patients with acute kidney injury and fluid overload. Findings reinforce Nuwellis' leadership in precision ultrafiltration for ...
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.
Pediatric nephrology and cardiology teams continue to seek out Aquadex for safe, precise fluid management in complex cases Pediatric nephrology and cardiology teams continue to seek out Aquadex for sa...
Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript
Nuwellis, Inc. ( NUWE) Q3 2025 Earnings Call November 12, 2025 9:00 AM EST Company Participants Leah McMullen - Director of Communications John Erb - Interim CFO, Interim Principal Financial & Accoun...
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing th...
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology
MINNEAPOLIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the c...
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
MINNEAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the c...
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results hi...
Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No.
Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment
Watch the “What This Means” segment here
Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
Awarded grant supports dedicated pediatric continuous renal replacement therapy (CRRT) device in development for patients between 2.5 and 20 kg where therapeutic options are scarce Company working to ...
Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
MINNEAPOLIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, announced plans to introduce a new 24-hour circuit for Aquadex therapy in the United States this fall.
Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administratio...
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from e...
Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it wi...
Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript
Nuwellis, Inc. (NASDAQ:NUWE) Q2 2025 Earnings Conference Call August 14, 2025 9:00 AM ET Company Participants John L. Erb - CEO, President & Chairman of the Board Leah McMullen - Corporate Participan...
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced ...
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced its decisi...